Press Releases

Date	Title and Summary	Additional Formats
Toggle SummaryFeb 6, 2014	Fluidigm Reports Strong Revenue for Q4 and the Full Year 2013 Fluidigm Reports Strong Revenue for Q4 and the Full Year 2013 - Full Year 2013 Revenue Up 36%   SOUTH SAN FRANCISCO, Calif. – February 6, 2014 – Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the fourth quarter and full year ended December 31, 2013.	View HTML Strong Revenue For Q4 - Full Year 2013 Revenue Up 36% 352.2 KB
Toggle SummaryJan 31, 2014	Fluidigm to Announce Q4/Full Year 2013 Financial Results and Host Conference Call for Investors Fluidigm to Announce Q4/Full Year 2013 Financial Results and Host Conference Call for Investors   SOUTH SAN FRANCISCO, Calif., Jan. 31, 2014 — Fluidigm Corporation (NASDAQ:FLDM) will report its fourth quarter and 2013 full year financial results on February 6, 2014, after close of market.	View HTML Q4/Full Year 2013 Financial Results 12.7 KB
Toggle SummaryJan 30, 2014	Fluidigm Announces Pricing of $175 Million Convertible Senior Notes Offering Fluidigm Announces Pricing of $175 Million Convertible Senior Notes Offering   SOUTH SAN FRANCISCO, CALIFORNIA, – January 30, 2014 – Fluidigm Corporation (NASDAQ: FLDM), a supplier of microfluidic systems for growth markets in the life science and agricultural biotechnology industries, today	View HTML Pricing Of $175 Million Convertible Senior Notes Offering 12.7 KB
Toggle SummaryJan 29, 2014	Fluidigm Announces Proposed $175 Million Convertible Senior Notes Offering Fluidigm Announces Proposed $175 Million Convertible Senior Notes Offering    SOUTH SAN FRANCISCO, CALIFORNIA – January 29, 2014 – Fluidigm Corporation (NASDAQ: FLDM), a supplier of microfluidic systems for growth markets in the life science and agricultural biotechnology industries, today	View HTML Proposed $175 Million Convertible Senior Notes Offering 21.1 KB
Toggle SummaryJan 29, 2014	Fluidigm and DVS Sciences Announce Agreement for Fluidigm to Acquire DVS Sciences – Creating a Single-Cell Technology Powerhouse Combines DVS Sciences' High-Parameter Single-Cell Protein Analysis Platform with...	View HTML Fluidigm To Acquire DVS Sciences 21.1 KB
Toggle SummaryJan 14, 2014	Fluidigm Announces Preliminary Fourth Quarter 2013 Revenue and Issues 2014 Revenue Guidance Fluidigm Announces Preliminary Fourth Quarter 2013 Revenue and Issues 2014 Revenue Guidance   SOUTH SAN FRANCISCO, Calif. – Jan. 14, 2014 – Fluidigm Corporation (NASDAQ:FLDM) today announced total revenue for the fourth quarter of 2013 is expected to be approximately $21 million based on	View HTML Fluidigm Announces Preliminary Fourth Quarter 2013 Revenue 14 KB
Toggle SummaryJan 8, 2014	Fluidigm to Present at the 32nd Annual J.P. Morgan Healthcare Conference Fluidigm to Present at the 32nd Annual J.P. Morgan Healthcare Conference    SOUTH SAN FRANCISCO, Calif. – Jan. 8, 2014 – Fluidigm Corporation (NASDAQ:FLDM) today announced that President and Chief Executive Officer Gajus Worthington will present at the 32nd Annual J.P.	View HTML Fluidigm at 32nd Annual J.P. Morgan Healthcare Conference 11.7 KB
Toggle SummaryDec 31, 2013	Nature Selects "Single-Cell Sequencing" The Method Of Year Nature Selects "Single-Cell Sequencing" as the 2013 Method of the Year Fluidigm Technology Accelerates the Adoption and Impact of Single-Cell Sequencing	View HTML Nature Selects "Single-Cell Sequencing" The Method Of Year 18.9 KB
Toggle SummaryDec 24, 2013	Fluidigm Launches Single-Cell DNA Sequencing Workflow to Study Somatic Mutations in Heterogenous Samples Fluidigm Launches Single-Cell DNA Sequencing Workflow to Study Somatic Mutations in Heterogenous Samples Universal Sample Prep Workflow on C1&#8482 Single-Cell Auto Prep System Simplifies Genome-Wide and Targeted Sequencing	View HTML Single-Cell DNA Sequencing Workflow Study Somatic Mutation 19.9 KB
Toggle SummaryNov 27, 2013	Fluidigm to Present at the 25th Annual Piper Jaffray Healthcare Conference For Immediate Release	View HTML Fluidigm At 25th Annual Piper Jaffray Healthcare Conference 11.7 KB